Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- molecules-24-00266
Final published version, 2.21 MB, PDF document
| Original language | English |
|---|---|
| Article number | 266 |
| Journal | Molecules |
| Volume | 24 |
| Issue number | 2 |
| Number of pages | 13 |
| ISSN | 1420-3049 |
| DOIs | |
| Publication status | Published - 2019 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 211863219